These metabolic changes provide a mechanistic bridge to the subsequent alterations in microbial abundance, since SCFAs not only result from but also shape the ecological structure of the gut microbiota
GLP-1 drugs can provide benefits for people with diabetes and obesity, but their effects on individuals with hemophilia remain uncertain due to limited research
GLP-1 medications are increasingly used to manage blood sugar and assist with weight loss, but they come with less obvious risks, particularly to muscle and bone health
Hair Regrowth: Formulations designed to stimulate hair follicles and improve scalp health
Trujillo JM, Nuffer W, Ellis SL (2015) GLP-1 receptor agonists: a review of head-to-head clinical studies
Leveraging fine-mapping and multipopulation training data to improve cross-population polygenic risk scores